MLEC Stock Analysis: Buy, Sell, or Hold?
MLEC - Moolec Science SA Ordinary Shares
$7.03
-0.36 (-4.87%)
âŧ
5d:
-1.54%
30d:
-0.71%
90d:
-3.03%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Apr 15, 2026
0d
Get Alerted When MLEC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MLEC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MLEC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MLEC is currently trading at $7.03, which is considered fair relative to its 30-day fair value range of $6.72 to $7.41.
Technical Outlook: Technically, MLEC is in a downtrend. Immediate support is located at $6.60, while resistance sits at $8.02. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MLEC is in a downtrend. Immediate support is located at $6.60, while resistance sits at $8.02. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$6.72 -
$7.41
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BEARISH: Trading 57.3% above Wall St target ($3.00)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.72 -
$7.41
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.60
Resistance Level
$8.02
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Wall Street Target
$3.00
(-57.3%)
Revenue Growth (YoY)
948.3%
Share & Embed Analysis
Last updated: September 13, 2026 8:21 AM ET
Data refreshes hourly during market hours. Next update: 9:21 AM
Data refreshes hourly during market hours. Next update: 9:21 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLEC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 60 BUY |
|
JSPR
Jasper Therapeutics Inc |
STRONG BUY
11 analysts |
$7 | 62 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
